Literature DB >> 22407964

DyeCycle Violet used for side population detection is a substrate of P-glycoprotein.

Maximilian Boesch1, Daniel Reimer, Holger Rumpold, Alain G Zeimet, Sieghart Sopper, Dominik Wolf.   

Abstract

Cancer stem cells (CSC) are increasingly recognized as key target cells for cancer therapy because they are both tumorigenic and chemoresistant and, therefore, can give rise to recurrent disease. Side population (SP) sorting using an ultraviolet (UV) laser is an established method to isolate CSC based on ABC drug transporter-dependent (e.g., ABCG2) Hoechst 33342 efflux. We here show that Vybrant® DyeCycle™ Violet (DCV), a DNA-binding fluorophor allowing SP sorting using a non-UV laser (such as violet laser), is transported via P-glycoprotein (PgP). Because PgP might be particularly abundant in multidrug-resistant cancer cells rather than bona fide CSC, investigators using DCV should be aware that this strategy might also detect PgP-expressing non-CSC.
Copyright © 2012 International Society for Advancement of Cytometry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407964     DOI: 10.1002/cyto.a.22038

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  11 in total

1.  Identification of drug-resistant subpopulations in canine hemangiosarcoma.

Authors:  A Khammanivong; B H Gorden; A M Frantz; A J Graef; E B Dickerson
Journal:  Vet Comp Oncol       Date:  2014-08-11       Impact factor: 2.613

2.  Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.

Authors:  Maximilian Boesch; Alain G Zeimet; Holger Rumpold; Guenther Gastl; Sieghart Sopper; Dominik Wolf
Journal:  Stem Cells Transl Med       Date:  2015-07-01       Impact factor: 6.940

Review 3.  Leukemic stem cells: identification and clinical application.

Authors:  Diana Hanekamp; Jacqueline Cloos; Gerrit Jan Schuurhuis
Journal:  Int J Hematol       Date:  2017-03-29       Impact factor: 2.490

4.  Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples.

Authors:  Maximilian Boesch; Elisabeth Hoflehner; Dominik Wolf; Guenther Gastl; Sieghart Sopper
Journal:  J Vis Exp       Date:  2017-05-10       Impact factor: 1.355

Review 5.  Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche.

Authors:  Maximilian Boesch; Sieghart Sopper; Alain G Zeimet; Daniel Reimer; Guenther Gastl; Burkhard Ludewig; Dominik Wolf
Journal:  Biochim Biophys Acta       Date:  2016-10-15

6.  Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population Phenotype.

Authors:  Maximilian Boesch; Dominik Wolf; Sieghart Sopper
Journal:  Stem Cells Int       Date:  2015-12-20       Impact factor: 5.443

7.  Application of JC1 for non-toxic isolation of cells with MDR transporter activity by flow cytometry.

Authors:  J Mario Wolosin; Aldo Zamudio; Zheng Wang
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

8.  Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression Model.

Authors:  Michaela Kripnerová; Hamendra Singh Parmar; Jiří Šána; Alena Kopková; Lenka Radová; Sieghart Sopper; Krzysztof Biernacki; Jan Jedlička; Michaela Kohoutová; Jitka Kuncová; Jan Peychl; Emil Rudolf; Miroslav Červinka; Zbyněk Houdek; Pavel Dvořák; Kateřina Houfková; Martin Pešta; Zdeněk Tůma; Martina Dolejšová; Filip Tichánek; Václav Babuška; Martin Leba; Ondřej Slabý; Jiří Hatina
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

9.  The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics.

Authors:  Maximilian Boesch; Alain G Zeimet; Daniel Reimer; Stefan Schmidt; Guenther Gastl; Walther Parson; Franziska Spoeck; Jiri Hatina; Dominik Wolf; Sieghart Sopper
Journal:  Oncotarget       Date:  2014-08-30

10.  A new fluorescent dye accumulation assay for parallel measurements of the ABCG2, ABCB1 and ABCC1 multidrug transporter functions.

Authors:  Edit Szabó; Dóra Türk; Ágnes Telbisz; Nóra Kucsma; Tamás Horváth; Gergely Szakács; László Homolya; Balázs Sarkadi; György Várady
Journal:  PLoS One       Date:  2018-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.